Found 0 matching trials
A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System PHASE2 The purpose of this study is to determine whether ABI-009 will make advance...
Show More Location
Ochsner Clinic Foundation
Learn More & Join Trial
Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study PHASE4 Our hypothesis is to test that 1) The safety and efficacy of Nano+ DES in p...
Show More Location
UZ Virga Jesse Ziekenhuis
Learn More & Join Trial
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma PHASE1 This is a multicenter, open label, single arm, phase I/II study. There will...
Show More Location
Universitätsmedizin Mainz
Learn More & Join Trial
Tolerance by Engaging Antigen During Cellular Homeostasis PHASE1 Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Show More Location
Duke University Health System
Learn More & Join Trial
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies PHASE1 This is an exploratory, open-label, investigator-initiated trial (IIT) of t...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence PHASE4 Cytomegalovirus is the most important opportunistic infection after kidney ...
Show More Learn More & Join Trial
Calcineurin Inhibitor Based Immunosuppression Withdrawal NA Damage and scarring of a transplanted kidney has become the most common cau...
Show More Location
Pediatric Nephrology of Alabama
Learn More & Join Trial
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment PHASE1 This is a phase 1, multi-center, open-label, dose-escalation study of nab-s...
Show More Location
South Texas Accelerated Research Therapeutics, LLC
Learn More & Join Trial
Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038) PHASE2 To describe the long-term safety of deforolimus (ridaforolimus, MK-8669) in...
Show More Location
Multiple Locations
Learn More & Join Trial
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) PHASE2 The immune system has offensive and defensive capacities. In bone marrow tr...
Show More Location
Katholieke Universiteit Leuven
Learn More & Join Trial